N Giordano

Summary

Affiliation: University of Siena
Country: Italy

Publications

  1. ncbi Expression of RXFP1 in skin of scleroderma patients and control subjects
    N Giordano
    Department of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, University of Siena, Siena University Hospital Santa Maria alle Scotte, Viale Bracci, Siena, Italy
    Scand J Rheumatol 41:391-5. 2012
  2. ncbi Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis
    N Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy
    J Biol Regul Homeost Agents 25:487-92. 2011
  3. ncbi Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study
    N Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    Int J Immunopathol Pharmacol 23:1185-94. 2010
  4. ncbi Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    New Microbiol 28:311-7. 2005
  5. ncbi Serum relaxin in systemic sclerosis
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy
    J Rheumatol 32:2164-6. 2005
  6. ncbi Possible pathogenetic role of antiphospholipid antibodies in a clinical case of human immunodeficiency virus infection with peripheral polyneuropathy and arterial thrombosis
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    New Microbiol 28:261-3. 2005
  7. ncbi Acute hepatitis induced by cyproterone acetate
    N Giordano
    Institute of Internal Medicine, University of Siena, Italy
    Ann Pharmacother 35:1053-5. 2001
  8. ncbi IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy
    N Giordano
    Department of Internal Medicine, University of Siena, Viale Bracci 1, 53100 Siena, Italy
    Clin Rheumatol 22:256-8. 2003
  9. ncbi Hyperuricemia and gout in thyroid endocrine disorders
    N Giordano
    Institute of Internal Medicine, University of Siena, Italy
    Clin Exp Rheumatol 19:661-5. 2001
  10. ncbi Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms
    R Guerranti
    Department of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, Faculty of Medicine, University of Siena, Siena, Italy
    Int J Immunopathol Pharmacol 23:901-9. 2010

Collaborators

Detail Information

Publications19

  1. ncbi Expression of RXFP1 in skin of scleroderma patients and control subjects
    N Giordano
    Department of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, University of Siena, Siena University Hospital Santa Maria alle Scotte, Viale Bracci, Siena, Italy
    Scand J Rheumatol 41:391-5. 2012
    ..The aim of this study was to define the pattern of expression of LGR7 in different types of human skin cells and to compare normal skin with lesional and unaffected skin from patients with limited SSc (lSSc)...
  2. ncbi Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis
    N Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy
    J Biol Regul Homeost Agents 25:487-92. 2011
    ..The aim of this review is to clarify the ET-1 role in SSc, in particular the relationship between ET-1 and cytokine expression, adding another element to the understanding of scleroderma disease...
  3. ncbi Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study
    N Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    Int J Immunopathol Pharmacol 23:1185-94. 2010
    ..01) in the whole cohort. The present data suggest that Bosentan is effective in stabilizing the microcirculation involvement and in improving skin fibrosis irrespective of scleroderma patterns...
  4. ncbi Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    New Microbiol 28:311-7. 2005
    ..5%), autoimmune anemia (0.3%) and oral lichen planus (0.3%). We claim that HCV liver infection is able to induce immune and autoimmune perturbations, without playing a significant role in the pathogenesis of a well-defined disorder...
  5. ncbi Serum relaxin in systemic sclerosis
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy
    J Rheumatol 32:2164-6. 2005
    ..To evaluate serum levels of relaxin (RLX), a hormone with acknowledged antifibrotic activity, in patients with systemic sclerosis (SSc)...
  6. ncbi Possible pathogenetic role of antiphospholipid antibodies in a clinical case of human immunodeficiency virus infection with peripheral polyneuropathy and arterial thrombosis
    Nicola Giordano
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    New Microbiol 28:261-3. 2005
    ..We suggest that the evaluation of serum antiphospholipid antibodies levels in HIV infection is fundamental both from an exploratory point of view and for starting the best treatment...
  7. ncbi Acute hepatitis induced by cyproterone acetate
    N Giordano
    Institute of Internal Medicine, University of Siena, Italy
    Ann Pharmacother 35:1053-5. 2001
    ..To report a case of acute hepatitis resulting from the use of cyproterone acetate, an adjuvant treatment for prostate cancer...
  8. ncbi IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy
    N Giordano
    Department of Internal Medicine, University of Siena, Viale Bracci 1, 53100 Siena, Italy
    Clin Rheumatol 22:256-8. 2003
  9. ncbi Hyperuricemia and gout in thyroid endocrine disorders
    N Giordano
    Institute of Internal Medicine, University of Siena, Italy
    Clin Exp Rheumatol 19:661-5. 2001
    ..The present study evaluates the prevalence of hyperuricemia and gout in patients affected by primary hypothyroidism and hyperthyroidism...
  10. ncbi Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms
    R Guerranti
    Department of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, Faculty of Medicine, University of Siena, Siena, Italy
    Int J Immunopathol Pharmacol 23:901-9. 2010
    ..According to our results, the c and e spots can be considered markers for SSc and thus be of use for the early diagnosis of connective tissue disorders and in establishing appropriate treatment...
  11. ncbi Efficacy and safety of a musically modulated electromagnetic field (TAMMEF) in patients affected by knee osteoarthritis
    E Battisti
    Department of Medical Physics, University of Siena, Italy
    Clin Exp Rheumatol 22:568-72. 2004
    ..In our study we want to value the effects of the TAMMEF (Therapeutic Application of a Musically Modulated Electromagnetic Field) system, which field is piloted by a musical signal...
  12. ncbi Comparison between the analgesic and therapeutic effects of a musically modulated electromagnetic field (TAMMEF) and those of a 100 Hz electromagnetic field: blind experiment on patients suffering from cervical spondylosis or shoulder periarthritis
    M Rigato
    Department of Physics, Section of Medical Physics University of Sienna, Italy
    J Med Eng Technol 26:253-8. 2002
    ..One group was exposed to the new TAMMEF, another group to the usual ELF, and the third group to simulated treatment. The results show that the effects of the new TAMMEF therapy are equivalent to those obtained with the ELF...
  13. ncbi Prevalence of Paget's disease of bone in Italy
    Luigi Gennari
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Siena, and Department of Radiology, U O A I S Giovanni Battista Hospital of Torino, Italy
    J Bone Miner Res 20:1845-50. 2005
    ..7% to 2.4%, were higher in males than in females, and slightly differed between the two towns. Unlike previous studies in populations of British descent, no secular trend for a decreasing prevalence emerged...
  14. ncbi Alterations in adenylate kinase activity in human PBMCs after in vitro exposure to electromagnetic field: comparison between extremely low frequency electromagnetic field (ELF) and therapeutic application of a musically modulated electromagnetic field (TA
    Antonietta Albanese
    TAMMEF Centre, University of Siena, Siena 53100, Italy
    J Biomed Biotechnol 2009:717941. 2009
    ..In contrast, TAMMEF fields may be useful for maintaining and regulating the cellular electrical charge...
  15. ncbi In vitro exposure of human osteoarthritic chondrocytes to ELF fields and new therapeutic application of musically modulated electromagnetic fields: biological evidence
    D Vannoni
    Department of Internal Medicine, Endocrine Metabolic Sciences and Biochemistry, University of Siena, Italy
    J Biol Regul Homeost Agents 26:39-49. 2012
    ..We can conclude that both ELF and TAMMEF systems could be recommended for OA therapy and represent a valid non-pharmacological approach to the treatment of this pathology...
  16. ncbi Magnetic resonance imaging in Tietze's syndrome
    L Volterrani
    Department of Human Pathology and Oncology, Department of Clinical and Immunological Science, University of Siena, Siena, Italy
    Clin Exp Rheumatol 26:848-53. 2008
    ..To evaluate the usefulness of magnetic resonance imaging (MRI) in Tietze's syndrome which, to our knowledge, has not previously been reported in the literature...
  17. ncbi H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease
    Cristina Lenzi
    Department of Internal Medicine Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy
    World J Gastroenterol 12:7815-20. 2006
    ..007). CONCLUSION: CagA positive H pylori infection may concur to the development of CHD; high levels of anti-Hsp60 antibodies may constitute a marker and/or a concomitant pathogenic factor of the disease...
  18. ncbi HLA antigens and primary osteoarthritis of the hand
    Daniela Merlotti
    Department of Internal Medicine, University of Siena, Italy
    J Rheumatol 30:1298-304. 2003
    ..Haplotype analysis showed an association of B35-DQ1, B40-DQ1, and DR2-DQ1 with increased OA risk. CONCLUSION: Our results suggest a role of the HLA system in the etiopathogenesis of primary OA of the hand...
  19. ncbi Is polymyalgia rheumatica caused by infectious agents?
    Ranuccio Nuti
    J Rheumatol 32:200-1. 2005